TROXYCA Drug Patent Profile
✉ Email this page to a colleague
When do Troxyca patents expire, and what generic alternatives are available?
Troxyca is a drug marketed by Pfizer and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in TROXYCA is naltrexone hydrochloride; oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Additional details are available on the naltrexone hydrochloride; oxycodone hydrochloride profile page.
DrugPatentWatch® Generic Entry Outlook for Troxyca
Indicators of Generic Entry
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TROXYCA?
- What are the global sales for TROXYCA?
- What is Average Wholesale Price for TROXYCA?
Summary for TROXYCA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | TROXYCA at DailyMed |
US Patents and Regulatory Information for TROXYCA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | TROXYCA ER | naltrexone hydrochloride; oxycodone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 207621-001 | Aug 19, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Pfizer | TROXYCA ER | naltrexone hydrochloride; oxycodone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 207621-004 | Aug 19, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Pfizer | TROXYCA ER | naltrexone hydrochloride; oxycodone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 207621-002 | Aug 19, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Pfizer | TROXYCA ER | naltrexone hydrochloride; oxycodone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 207621-003 | Aug 19, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
